Gene and Cell Therapy
A section of Pharmaceutics (ISSN 1999-4923).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Gene Therapy for Neurological Disease (Deadline: 31 March 2024)
- Editorial Board Members’ Collection Series: Progress and Challenges of Gene Delivery Systems (Deadline: 10 April 2024)
- Where Are We Now and Where Is Cell Therapy Headed? (Deadline: 20 April 2024)
- Application Prospects and Challenges of Cell-Penetrating Peptides in Drug Delivery Systems (Deadline: 30 April 2024)
- Mesenchymal Stem/Stromal Cell Extracellular Vesicles: From Active Principle to Next Generation Drug Delivery (Deadline: 10 May 2024)
- The Delivery of RNA-Based Therapeutics: New Strategies in Cancer and Gene Therapy (Deadline: 20 May 2024)
- Mesenchymal Stromal Cell-Based Cell Therapy: Recent Advances and Expectations (Deadline: 31 May 2024)
- Delivery of Oligonucleotide Therapeutics (Deadline: 10 June 2024)
- mRNA Therapeutics for Cancer Treatment (Deadline: 20 June 2024)
- Nanoformulations for Delivering Small Molecules, Biologics, and Gene Modalities against Neurodegenerative Diseases/Disorders (Deadline: 20 June 2024)
- Extracellular Vesicles for Cancer Therapy (Deadline: 20 June 2024)
- Current State of the Field of Cell-Penetrating Peptides as an Honorific Issue for Professor Ülo Langel (Deadline: 30 June 2024)
- Delivery of Oligonucleotide-Based Therapeutics (Deadline: 30 June 2024)
- Editorial Board Members’ Collection Series: Targeted Delivery of Anticancer Agents Engaging Cell Specific Mechanisms (Deadline: 30 June 2024)
- Intelligent Nanomaterials for Gene Therapy (Deadline: 1 July 2024)
- Cyclodextrins and Associated Nanomaterials for Drug and Gene Delivery (Deadline: 15 July 2024)
- Nanocarriers: A Novel Strategy for Cell and Gene Delivery (Deadline: 20 July 2024)
- State-of-Art in mRNA Therapeutics and Gene Delivery (Deadline: 20 July 2024)
- Mesenchymal Stem Cell-Derived Extracellular Vesicles as Therapeutics, 2nd Edition (Deadline: 31 July 2024)
- Bacteriophages, Critical Biocatalysts of Bacterial Doom: The Dawn of a New Era in the Fight against Multidrug Resistant Bacteria, 2nd Edition (Deadline: 31 July 2024)
- Plasmid DNA for Gene Therapy and DNA Vaccine Applications, 2nd Edition (Deadline: 10 August 2024)
- Stromal, Stem, Signaling Cells: The Multiple Roles and Applications of Mesenchymal Cells, 2nd Edition (Deadline: 15 August 2024)
- Recent Advances in Adeno-Associated Virus-Mediated Gene Therapy and Vaccine Development (Deadline: 20 September 2024)
- Cancer Gene Therapy with Non-viral Nanocarriers, 2nd Edition (Deadline: 20 September 2024)
- Trends in mRNA Vaccine Development and Applications (Deadline: 30 September 2024)